Crenezumab (Anti-Amyloid Beta)
Product Specifications
CAS Number
1095207-05-8
Synonyms
MABT 5102A; RG 7412
Target
Beta Amyloid
Applications
Neuronal Signaling
Additionnal Information
Crenezumab (Anti-Amyloid Beta) is a fully humanized immunoglobulin (Ig) G4 monoclonal antibody that targets amyloid beta (Abeta) with potential for use in Alzheimer's disease research. MW: 143.58 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC942853-500 1x 500 µL
CD54 / ICAM-1 (15.2), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881231-100 1x 100 µL
Eosinophil Peroxidase (AHE-1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040669-100 1x 100 µL
P27 / KIP1 (SX53G8), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742147-500 1x 500 µL
Cytokeratin, Basic (Type II or HMW) (KRTH/2147R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details